Guggenheim DJIA Ave Div

IBM commits to training 5 million Indians in AI, cybersecurity, and quantum tech by 2030

UnitedHealth Group (UNH) monthly options expire on December 19, 2025

Cisco Systems Director Sells Company Stocks

Chevron Prepares to Export 1 Million Barrels of Oil from Venezuela

BMO Capital Raises Merck's Target Price to $130

Kodiak AI Inc. Signs 5G Connectivity and IoT Collaboration Agreement with Verizon Business

Optum Rx Expands Cost-Based Reimbursement Model to All In-Network Community Pharmacies

Johnson & Johnson Medical Devices Receives FDA Approval for TRUFILL n-BCA for Chronic Subdural Hematoma

UnitedHealth reportedly transfers risk via reinsurance deal covering stop-loss and dental business

Chesley Taft & Associates LLC Reduced Holdings in UnitedHealth Group in Q3

Channel Wealth LLC Reduced Procter & Gamble Stake in Q3

Multiple Banks Update Analyst Ratings and Price Targets for UnitedHealth Group

Acropolis Investment Management LLC Increased Holdings in UnitedHealth and Disclosed Third Quarter Earnings

Czech National Bank Increases Stake in UnitedHealth Group by 3.7%

JPMorgan Downgrades P&G Target Price to $157

Bank of America Securities analyst says UnitedHealth is well-positioned with a supportive rate environment.

Wedmont Private Capital Significantly Increases Holdings in UnitedHealth Group

Rep. Gilbert Ray Cisneros, Jr. Sells UnitedHealth Group Stock

FDA Approves Johnson & Johnson's RYBREVANT FASPRO for EGFR-Mutated Non-Small Cell Lung Cancer

FDA Accelerates Review of Merck's Experimental Drugs

Starfighters Space

Aimei Health Tech

T-Rex 2X Long DJT Daily Target ETF

Athira Pharma

Sable Offshore

Zeta Network

Vivakor

Safe and Green Development

Trump Media & Tech

VS MEDIA

Senator Bernie Sanders criticizes Congress for prioritizing $1 trillion military spending over healthcare and poverty alleviation, highlighting that U.S. defense expenditure surpasses the next nine nations combined. He argues that this misallocation of resources leaves millions without healthcare and contributes to high poverty rates. Sanders opposed the $901 billion National Defense Authorization Act signed by Trump, which includes a 4% pay raise for service members and funds for Ukraine's security. SIPRI data supports Sanders' claim about U.S. military spending.

benzinga_article

Unitedhealth

Bernie Sanders Says America's $1 Trillion Military Spending More Than 'Next Nine Nations Combined' As Millions Lack Healthcare, Children Face Poverty

IBM commits to skill 5 million Indians in Artificial Intelligence, cybersecurity and quantum by 2030

marketscreener

IBM commits to skill 5 million Indians in Artificial Intelligence, cybersecurity and quantum by 2030

International Business Machines Corp :IBM - COMMITS TO SKILL 5 MILLION INDIANS IN AI, CYBERSECURITY & QUANTUM BY 2030

Reuters

IBM Commits To Skill 5 Million Indians In AI, Cybersecurity & Quantum By 2030

U.S. Gulf of Mexico crude grades weakened after a previous spike due to U.S.-Venezuela tensions. Mars eased 80 cents, SGC $1.30. Chevron's shipments remain unaffected. Venezuela authorized two VLCCs to China. Oil futures rose slightly amid potential U.S. sanctions on Russia and Venezuelan tanker blockades. Light Louisiana Sweet, Mars Sour, WTI Midland, and West Texas Sour saw varied price changes. Brent February futures rose 14 cents, WTI January futures 21 cents. Brent/WTI spread narrowed to minus $3.85.

Chevron

US Cash Crude-Offshore grades ease after spiking in previous session

Verizon Communications (NYSE:VZ) stock dropped 1.2% on Thursday, trading as low as $40.39. Analysts have adjusted price targets, with Morgan Stanley lowering to $47.00 and Scotiabank raising to $51.00. Verizon reported Q3 earnings of $1.21 per share, beating estimates. The company announced a quarterly dividend of $0.69 per share. Hedge funds have made changes to their positions in VZ. Verizon has a market cap of $170.37 billion and a PE ratio of 8.63.

Market Beat

Verizon

Verizon Communications (NYSE:VZ) Trading Down 1.2%  - Here's What Happened

CSCO

Johnson Kristina M Director of Cisco Systems Inc [CSCO] filed a Form 4 on December 18, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:DateTransactionSharesPriceValue12/16/25Exercise3,481$0.00N/A12/18/25Sale13,481$77.13$1,039,845Ending Holdings: 61,630 - DirectFor a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

Cisco

Dir Johnson Sells 13,481 ($1M) Of Cisco Systems Inc [CSCO]

Kristina M. Johnson, a Director at Cisco Systems Inc., has reported the disposal of common shares in the company. The details of this transaction are available through the EDGAR system of the U.S. Securities and Exchange Commission. This information is provided by Public Technologies using AI and is not financial advice.

Cisco Director Kristina M. Johnson Reports Disposal of Common Shares

Michael D. Capellas, Director of Cisco Systems Inc, filed a Form 144 with the SEC to sell 27,000 shares on December 18, 2025. The sale will be managed by JP Morgan Securities LLC. Form 144 is required for selling restricted stock, allowing sales within 90 days of filing. The Washington Service offers insider trading analysis and data services.

Dir Capellas Files To Sell 27,000 Of Cisco Systems Inc [CSCO]

LRCX

SBUX

CMCSV

Micron Tech(MU) rose 10.21%, with a trading turnover 16.3 Billion USD, and a year-to-date rose 196.2%. Lam Research(LRCX) rose 6.27%, with a trading turnover 2.2 Billion USD, and a year-to-date rose 130.1%. Comcast - WI(CMCSV) fell 4.38%, with a trading turnover 84.2 Thousand USD, and a year-to-date rose 7.9%. ConocoPhillips(COP) fell 2.87%, with a trading turnover 640.1 Million USD, and a year-to-date fell 3.8%.

- The Nasdaq Composite Index rose 1.38%, with a year-to-date increase of 19.1%.  
- The S&P 500 Index gained 0.79%, up 15.2% for the year, while the Dow Jones increased by 0.14%, showing a 12.7% rise year-to-date.  
- Notable movers included Micron Technology, which surged 10.21% and has risen 196.2% this year, and Lam Research, increasing 6.27% with a 130.1% year-to-date growth.

Top Gainers & Losers

Micron Tech

Lam Research

Constellation Energy

AppLovin

Starbucks

Comcast - WI

ConocoPhillips

ServiceNow

Automatic Data Process

Procter & Gamble

Top 5 US Stock Gainers/Losers (>100B) (12.18)

COKE

Investing $1000 in Coca-Cola Consolidated (NASDAQ:COKE) 10 years ago would now be worth $9,023.81, reflecting an annualized return of 24.61%, outperforming the market by 11.99%. The company's current market cap is $11.07 billion. This highlights the significant impact of compounded returns on investment growth over time.

- Coca-Cola Consolidated (NASDAQ:COKE) has achieved an annualized outperformance of 11.99% over the past 10 years, with an average annual return of 24.61%.  
- A $1,000 investment in COKE stock from 10 years ago would now be valued at $9,023.81, based on the current price of $166.25.  
- The article emphasizes the significant impact of compounded returns on cash growth over time.

Coca-Cola Bottling

Coca Cola

$1000 Invested In Coca-Cola Consolidated 10 Years Ago Would Be Worth This Much Today

Shares of Verizon Communications Inc. (VZ) fell 1.15% to $40.41 on Thursday, underperforming compared to competitors like Apple Inc. and T-Mobile US Inc. Despite a favorable trading session for the stock market, Verizon remains 14.67% below its 52-week high. Trading volume was significantly lower than the 50-day average.

Dow Jones

Verizon Communications Inc. Stock Underperforms Thursday When Compared To Competitors

Merck & Co. Inc.'s stock rose 1.52% to $100.69, outperforming competitors like Johnson & Johnson and Pfizer during a positive trading session. The stock is 4.87% below its 52-week high. Trading volume exceeded the 50-day average.

Merck

Merck & Co. Inc. Stock Outperforms Competitors On Strong Trading Day

The FDA has approved Johnson & Johnson's Rybrevant Faspro, a 5-minute subcutaneous injection for EGFR-mutated non-small cell lung cancer, offering higher patient convenience and lower healthcare burden compared to intravenous delivery. Additionally, the FDA expanded the use of J&J's TRUFILL n-BCA Liquid Embolic System for treating chronic subdural hematoma. J&J shares were down 0.70% at $208.86.

Johnson & Johnson

FDA Approves J&J's New 5-Minute Injection For Lung Cancer

ISRG

MDLN

HIMS

MarketBeat's stock screener tool highlights seven healthcare stocks to watch: UnitedHealth Group, Johnson & Johnson, Medline, Intuitive Surgical, McKesson, Hims & Hers Health, and Cencora. These companies have the highest dollar trading volume recently and are involved in various healthcare sectors, offering a mix of defensive and growth-oriented investment opportunities.